The fact that significant attenuation of these pathological changes occurred after treatment with gene silencing shRNAs or EGFR inhibitors provided strong evidence that aberrent EGFR signaling plays a crucial role in the pathogenesis of cardiac dysfunction and remodeling in diabetes (Liang et al., 2015). Here, EGFR is linked to diabetes mellitus.